Differences in clinical and laboratory biomarkers for short and long‐term respiratory outcomes in preterm neonates

Pulmonary outcome of premature neonates has focused more on short-term than long-term respiratory morbidities.Describe risk factors/biomarkers associated with short-term (bronchopulmonary dysplasia [BPD]) (supplemental oxygen use at 36 weeks postmenstrual age [PMA]) and longer-term (chronic respiratory morbidity [CRM]) (respiratory related symptoms, medications, medical/emergency visits, hospitalizations at 6-12 months corrected gestational age...